Dunhill Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41K Sell
4
-3
-43% -$986 ﹤0.01% 891
2025
Q4
$2.46K Buy
7
+2
+40% +$676 ﹤0.01% 708
2025
Q3
$1.65K Sell
5
-7
-58% -$2.18K ﹤0.01% 721
2025
Q2
$4.82K Sell
12
-10
-45% -$4.02K ﹤0.01% 551
2025
Q1
$9.62K Buy
22
+6
+38% +$2.41K ﹤0.01% 428
2024
Q4
$5.74K Sell
16
-55
-77% -$23K ﹤0.01% 516
2024
Q3
$37K Buy
71
+26
+58% +$13.9K 0.02% 196
2024
Q2
$24.5K Buy
45
+23
+105% +$12.2K 0.02% 192
2024
Q1
$11.6K Buy
22
+3
+16% +$1.49K 0.01% 216
2023
Q4
$9.11K Buy
+19
New +$8.79K 0.01% 221

Other funds holding ELV

Dunhill Financial's ELV Position: Q1 2026 in Review

Dunhill Financial reduced its Elevance Health (ELV) stake by 43% in Q1 2026, selling an estimated $986 and leaving 4 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Dunhill Financial first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $37K in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Dunhill Financial held 4 shares of Elevance Health worth $1.41K as of Q1 2026.
  • Dunhill Financial sold 3 Elevance Health shares in Q1 2026, an estimated $986.
  • Elevance Health made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #891 holding.
  • Dunhill Financial first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's Elevance Health position peaked at $37K in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.